Overview
Toshiyuki Miyata practices practicing medicine in Osaka, Japan.
Mr. Miyata is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Atypical Hemolytic Uremic Syndrome (aHUS), Thrombocytopenia, D-Plus Hemolytic Uremic Syndrome, Thrombectomy, and Splenectomy.
He is actively involved in clinical research, co-authoring 103 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Toshiyuki Miyata
Is Toshiyuki Miyata a top-rated expert for Atypical Hemolytic Uremic Syndrome (aHUS)?
MediFind is an objective health platform that identifies experts based on real-world data. Toshiyuki Miyata is classified as an Elite expert for Atypical Hemolytic Uremic Syndrome (aHUS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Toshiyuki Miyata participate in research or clinical trials?
Yes. Toshiyuki Miyata has published 103 articles and abstracts on conditions like Atypical Hemolytic Uremic Syndrome (aHUS). You can view a list of Toshiyuki Miyata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Atypical Hemolytic Uremic Syndrome (aHUS)
- D-Minus Hemolytic Uremic Syndrome
- D-Plus Hemolytic Uremic Syndrome
- Hemolytic-Uremic SyndromeMr. Miyata isElite. Learn about Hemolytic-Uremic Syndrome.
- ThrombocytopeniaMr. Miyata isElite. Learn about Thrombocytopenia.
- Distinguished
- PurpuraMr. Miyata isDistinguished. Learn about Purpura.
- Advanced
- AnemiaMr. Miyata isAdvanced. Learn about Anemia.
- Blood ClotsMr. Miyata isAdvanced. Learn about Blood Clots.
- Hemolytic AnemiaMr. Miyata isAdvanced. Learn about Hemolytic Anemia.
- Ligneous ConjunctivitisMr. Miyata isAdvanced. Learn about Ligneous Conjunctivitis.
- Protein S DeficiencyMr. Miyata isAdvanced. Learn about Protein S Deficiency.
- Venous Thromboembolism (VTE)Mr. Miyata isAdvanced. Learn about Venous Thromboembolism (VTE).
- Experienced
- AngioedemaMr. Miyata isExperienced. Learn about Angioedema.
- Atrial FibrillationMr. Miyata isExperienced. Learn about Atrial Fibrillation.
- Conjunctivitis (Pink Eye)Mr. Miyata isExperienced. Learn about Conjunctivitis (Pink Eye).
- Deep Vein ThrombosisMr. Miyata isExperienced. Learn about Deep Vein Thrombosis.
- HemolysisMr. Miyata isExperienced. Learn about Hemolysis.
- Hereditary AngioedemaMr. Miyata isExperienced. Learn about Hereditary Angioedema.
- High Molecular Weight Kininogen Deficiency
- HivesMr. Miyata isExperienced. Learn about Hives.
- HypertensionMr. Miyata isExperienced. Learn about Hypertension.
- JaundiceMr. Miyata isExperienced. Learn about Jaundice.
- Mesenteric Venous ThrombosisMr. Miyata isExperienced. Learn about Mesenteric Venous Thrombosis.
- Patent Ductus ArteriosusMr. Miyata isExperienced. Learn about Patent Ductus Arteriosus.
- Protein C DeficiencyMr. Miyata isExperienced. Learn about Protein C Deficiency.
- Pulmonary EmbolismMr. Miyata isExperienced. Learn about Pulmonary Embolism.
- SplenectomyMr. Miyata isExperienced. Learn about Splenectomy.
- StrokeMr. Miyata isExperienced. Learn about Stroke.
- ThrombectomyMr. Miyata isExperienced. Learn about Thrombectomy.
- Transient Ischemic Attack (TIA)Mr. Miyata isExperienced. Learn about Transient Ischemic Attack (TIA).